Feeds:
Posts
Comments

Posts Tagged ‘mass tort’

For those of you interested in the topic of statistics in mass and class actions, U. Conn. Law Professor and Mass Tort Litigation Blog contributor Alexandra D. Lahav has written an academic paper on the subject in the Texas Law Review, aptly entitled The Case for “Trial by Formula.”  For Professor Lahav’s synopsis of the paper, a link to [...]

Read Full Post »

In December, I posted this preview of the then forthcoming book, Drug and Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden (Oxford University Press 2011).  I received my copy of the book just before the holidays, and it is as good as advertised.  The book has many strengths.  It is comprehensive, generally accessible, eloquently written, [...]

Read Full Post »

This is the sixth and final installment of a multi-part post summarizing last week’s 5th Annual Conference on the Globalization of Class Actions and Mass Litigation.  Click these links to see the summaries for Session 1, Session 2, Session 3, Session 4, and Session 5. Paths to (Mass) Justice To wrap up the conference, Dr. Sam [...]

Read Full Post »

This is the fourth in a multi-part post summarizing last week’s 5th Annual Conference on the Globalization of Class Actions and Mass Litigation.  Click these links to see the summaries for Session 1, Session 2, and Session 3.  Giving Away Money: Calculating Damages & Allocating Damages Professor Francis McGovern, Duke University Law School chaired this [...]

Read Full Post »

Ok, just a bit further… Mark Herrmann, former contributor to the wildly successful Drug and Device Law Blog, sent me a note the other day that his book co-authored with Jones Day Partner David B. Alden entitled Drug and Device Product Liability Litigation Strategy (Oxford Univ. Press 2011) is now available.  Here is a link to [...]

Read Full Post »

Senior U.S. District Court Judge Jack B. Weinstein (E.D.N.Y), has become well known for his often-cited and sometimes controversial opinions in mass tort and class action cases.  He recently authored a commentary in the Cardozo Law Review’s new online journal de novo on some of his key decisions in cases involving subjects ranging from Agent Orange, asbestos, and tobacco to breast [...]

Read Full Post »

Follow

Get every new post delivered to your Inbox.